Erratum: Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis(J Clin Invest. (2014)124:3(1083–1097)DOI: 10.1172/JCI70391)

Yoko Kojima, Kelly Downing, Ramendra Kundu, Clint Miller, Frederick Dewey, Hope Lancero, Uwe Raaz, Ljubica Perisic, Ulf Hedin, Eric Schadt, Lars Maegdefessel, Tom Quertermous, Nicholas J. Leeper

Research output: Contribution to journalComment/debate

7 Scopus citations

Abstract

During the assembly of Figure 6A and Supplemental Figure 4C, incorrect flow cytometry plots were included. The authors were able to provide the original data, and a corrected version of Figure 6A appears below. The online version of the supplemental data has been updated with the corrected version of Supplemental Figure 4C.

Original languageEnglish
Pages (from-to)2164
Number of pages1
JournalJournal of Clinical Investigation
Volume129
Issue number5
DOIs
StatePublished - 1 May 2019

Fingerprint

Dive into the research topics of 'Erratum: Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis(J Clin Invest. (2014)124:3(1083–1097)DOI: 10.1172/JCI70391)'. Together they form a unique fingerprint.

Cite this